IP Library › Granted Patent US 7,723,488
Granted Patent B2
US 7,723,488 · App. 10/897,359 · Granted May 25, 2010

Monoclonal antibodies to secreted and transmembrane polypeptides

Assignee: Genentech, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,723,488
App. No.
10/897,359
Granted
May 25, 2010
Kind
B2
Abstract

The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.

Claims (4)

1. A monoclonal antibody or fragment thereof that specifically binds to the polypeptide of SEQ ID NO:400.

2. The antibody of claim 1 which is a humanized antibody.

3. The antibody of claim 1 which is an antibody fragment.

4. The antibody of claim 1 which is labeled.

Continuity (8)
Continuation 0997858500 · Oct 16, 2001
Continuation 0991858500 · Jul 30, 2001
Continuation PCTUS000434100 · Feb 18, 2000
Continuation In Part PCTUS992831300 · Nov 30, 1999
Continuation In Part 0938013800
Provisional Application 6013428700 · May 14, 1999
Provisional Application 6007972800 · Mar 27, 1998
Related Publication 20050037463A1 · Feb 17, 2005